First, cardiomyocyte viability, as evaluated through CCK8 assay, was reduced after exposure to hyperglycemia treatment whereas Exenatide treatment restored cardiomyocyte viability in a NF-κB-dependent manner. This evidence concerns the gene NFKB1 and Hyperglycemia.